ARTICLE | Company News
Calithera, Incyte deal
March 30, 2017 12:48 AM UTC
Calithera will receive a $12 million milestone payment from Incyte under a January deal granting Incyte exclusive, worldwide rights to CB-1158 for hematology and cancer indications. Calithera said the...